Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Saved in:
| Title: | Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group. |
|---|---|
| Authors: | Lübbert, Michael1 michael.luebbert@uniklinik-freiburg.de, Suciu, Stefan2, Hagemeijer, Anne3, Rüter, Björn1, Platzbecker, Uwe4, Giagounidis, Aristoteles5, Selleslag, Dominik6, Labar, Boris7, Germing, Ulrich8, Salih, Helmut9, Muus, Petra10, Pflüger, Karl-Heinz11, Schaefer, Hans-Eckart12, Bogatyreva, Lioudmila, Aul, Carlo13, Witte, Theo14, Ganser, Arnold15, Becker, Heiko1, Huls, Gerwin, Helm, Lieke16 |
| Source: | Annals of Hematology. Jan2016, Vol. 95 Issue 2, p191-199. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
